default author photo

Andrew B. Ward

The Scripps Research Institute - Department of Integrative Structural and Computational Biology

10550 North Torrey Pines Road

La Jolla, CA 92037

United States

The Scripps Research Institute - Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery

La Jolla, CA

United States

The Scripps Research Institute - IAVI Neutralizing Antibody Center

La Jolla, CA

United States

SCHOLARLY PAPERS

8

DOWNLOADS

318

TOTAL CITATIONS

11

Scholarly Papers (8)

Mapping Neutralizing Antibody Epitope Specificities to an HIV Env Trimer in Immunized and in Infected Rhesus Macaques

Number of pages: 37 Posted: 28 Jul 2020
The Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Immunology and Microbiology, Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Immunology and Microbiology, National Institutes of Health - Vaccine Research Center, International AIDS Vaccine Initiative, The Scripps Research Institute - Department of Immunology and Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Immunology and Microbiology and International AIDS Vaccine Initiative
Downloads 33 (1,311,254)
Citation 1

Abstract:

Loading...

2.

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Number of pages: 53 Posted: 17 Aug 2020
University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, TEGA Therapeutics, TEGA Therapeutics, Pennsylvania State University - Department of Biochemistry and Molecular Biology, Pennsylvania State University - Department of Biochemistry and Molecular Biology, University of Copenhagen - Copenhagen Center for Glycomics, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, University of California, San Diego (UCSD) - Department of Chemistry and Biochemistry, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Department of Chemistry and Biochemistry, Ragon Institute of MGH, MIT and Harvard, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, University of California, San Diego (UCSD) - Department of Bioengineering, University of California, San Diego (UCSD) - Department of Bioengineering, University of California, San Diego (UCSD) - Department of Medicine, University of California, San Diego (UCSD) - Department of Pediatrics, Sanford Burnham Prebys Medical Discovery Institute - Immunity and Pathogenesis Program, Ragon Institute of MGH, MIT and Harvard, University of California, San Diego (UCSD) - Department of Chemistry and Biochemistry, Pennsylvania State University - Department of Biochemistry and Molecular Biology, University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of California, San Diego (UCSD) - Department of Medicine and University of California, San Diego (UCSD) - Department of Cellular and Molecular Medicine
Downloads 56 (1,000,027)
Citation 6

Abstract:

Loading...

COVID-19, SARS-CoV-2, Coronavirus, Spike proteins, Heparin,Heparan Sulfate,Pseudotype virus

3.

Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection

Number of pages: 42 Posted: 24 Nov 2020
University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Life and Soft, Institut Cochin, University of Southampton - School of Biological Sciences, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Department of Viroscience, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Washington - Department of Biochemistry, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), AIMM Therapeutics BV, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Erasmus Medical Center - Viroscience Department, University of Amsterdam - Amsterdam Public Health Research Institute, Life and Soft, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, University of Washington - Department of Biochemistry, University of Paris-Saclay - Molecular Genetics of RNA Viruses, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Amsterdam - Department of Medical Microbiology
Downloads 51 (1,052,702)

Abstract:

Loading...

SARS-CoV-2 vaccine, Self-assembling protein nanoparticle vaccine, SARS-CoV-2 NHP challenge study

4.

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects

Number of pages: 55 Posted: 01 Apr 2021
Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Emory University - Department of Pediatrics, Emory University - Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Emory University - Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, National Institutes of Health (NIH) - Vaccine Research Center, University of Washington - Division of Allergy and Infectious Diseases, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington - Department of Pediatrics, Centre de Recherche du CHUM, Emory University - Center for Childhood Infections and Vaccines, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division
Downloads 47 (1,097,529)
Citation 4

Abstract:

Loading...

SARS-CoV-2, SARS-CoV-1, S2 subunit, RBD, NTD, neutralization, monoclonal antibodies, B.1.351

5.

HIV-1 Germline-Targeting Vaccine Regimen Selects for Rare Immunoglobulin Insertions and Deletions Typical of VRC01-Class Antibodies

Number of pages: 49 Posted: 21 Sep 2022
University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Applied Biomedical Science Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Applied Biomedical Science Institute, University of Amsterdam - Department of Medical Microbiology, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Cornell University - Department of Microbiology and Immunology, Applied Biomedical Science Institute, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, Cornell University - Department of Microbiology and Immunology, Cornell University - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Duke University - Duke Human Vaccine Institute, Applied Biomedical Science Institute and University of Amsterdam - Department of Medical Microbiology
Downloads 46 (1,109,210)

Abstract:

Loading...

HIV-1 Env, vaccines, germline-targeting, insertions, deletions, neutralizing antibodies, bNAbs, mouse model, NGS

6.

DNA electroporation of HIV Env elicits unique pattern of immune responses compared to other methods of immunogen delivery, including robust CD8+ responses and memory B cell responses with muted serum antibody levels when boosted with recombinant protein

Number of pages: 32 Posted: 01 Oct 2025
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Alabama at Birmingham, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, affiliation not provided to SSRN, Duke University - Duke Human Vaccine Institute, Duke University, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Department of Surgery, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute, National Institutes of Health, affiliation not provided to SSRN, Columbia University, Vanderbilt University - Division of Infectious Diseases, affiliation not provided to SSRN, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, affiliation not provided to SSRN, Government of the United States of America - Vaccine Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and University of Pennsylvania - Vaccine Center
Downloads 42 (1,157,785)

Abstract:

Loading...

HIV-1 vaccine, DNA vaccine, Clinical Trial, neutralizing antibodies, B cell response, CD8+ T cell response

7.

Broadly Neutralizing Antibodies Against Conserved Epitopes of the Hemagglutinin Head are Robustly Recalled by a Novel H1N1 Virus

Number of pages: 60 Posted: 24 Nov 2020
University of Chicago - Section of Rheumatology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Chicago - Section of Rheumatology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, University of Chicago - Section of Rheumatology, University of Chicago - Committee on Immunology, University of Chicago - Committee on Immunology, University of Chicago - Section of Rheumatology, University of Chicago - Section of Rheumatology, University of Chicago - Section of Rheumatology, University of Chicago - Section of Rheumatology, University of Chicago - Section of Rheumatology, University of Chicago - Section of Rheumatology, University of Chicago - Section of Rheumatology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology and University of Chicago - Section of Rheumatology
Downloads 34 (1,263,436)

Abstract:

Loading...

H1N1; hemagglutinin head; lateral patch; receptor-binding site; broadly neutralizing antibodies

8.

Natural Signal Peptide Modifications Improve Authentic HIV-1 gp120/gp41 Trimer Expression

Number of pages: 39 Posted: 06 May 2026
San Diego Biomedical Research Institute, The Scripps Research Institute, University of Southampton, San Diego Biomedical Research Institute, San Diego Biomedical Research Institute, San Diego Biomedical Research Institute, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, University of Southampton - School of Biological Sciences, The Scripps Research Institute and San Diego Biomedical Research Institute
Downloads 9 (1,548,648)

Abstract:

Loading...

HIV, Env, gp120, gp160, gp41, signal peptide, gp120/gp41, trimer, Vaccine, glycoprotein, LC-MS, AlphaFold, molecular dynamics modeling